Nuevolution

Developer of drug treatments for oncology and chronic inflammatory diseases

placeCopenhagen, Capital Region Of Denmark, Denmark calendar_todayFounded 2001 groups40 employees language nuevolution.com

Registered entities

Innovation

1 patent family (1 granted) — focus: Chemistry & metallurgy; filing pace dormant. Cited 66 times.

YearFilings
20171

Investor mix

6 investors on record; lead investors include SLS Venture, Novo Holdings, Industrifonden; 1 has since exited.

Investor typeCountShare
Venture capital467%
Other / undisclosed233%
Coming soon